Yes, which is completely ridiculous considering Novogen is still a preclinical company. I don't know if they're trying to save on market release filing fees or what. The only thing I find encouraging is that the list of upcoming events on the Novogen.com site is getting longer and longer: http://www.novogen.com/events.html
NRT Price at posting:
11.0¢ Sentiment: Buy Disclosure: Held